MILAN (AIMnews.it) - KOLINPHARMA, during the 3 days of the convention at the beginning of the year, presents two new products: XINEPA tablets and ALMETAX tablets. The new products are characterized by a different pharmaceutical form compared to the products already on the price list and represent the result of a technological and development path fruitfully conducted by the internal department of Research and Development. The tablet format of XINEPA and ALMETAX will allow to reach a new target of patients and to expand the commercial offer on the reference market. XINEPA tablets is a dietary supplement for the treatment of peripheral neuropathies; while ALMETAX tablets is a dietary supplement for the maintenance of psychophysical well-being during the menopause. "We are very proud to present to the market, during our convention at the beginning of the year, the 2 new products XINEPA tablets and ALMETAX tablets, - comments Rita Paola Petrelli, President of KOLINPHARMA - which testify how the investments and efforts made by our Research and Development department translate into concrete results that can create value for our Company and our stakeholders. 2019 marked the achievement of extremely positive goals and presenting ourselves to the new year in this way gives us great confidence also for 2020".